Search results

Search Web pagesPDFs

Results will auto-populate based on filter selection.

Filters
Forms
News Release
Operational Policy Manual
(-) Page
Keywords
FAQ
Forms
Provider profile
Found 626 result(s)
Drug formulary listing decision – Oxycodone/naloxone controlled release
Indication(s)The relief of moderate to severe pain in adults who require continuous opioid analgesia for several days or more. The naloxone component is indicated for the…
Drug formulary listing decision – Paliperidone
Indication(s)Treatment of schizophrenia.DAC recommendationThe Drug Advisory Committee (DAC) recommended that paliperidone not be listed on any WSIB formularies as there are…
Drug formulary listing decision – Piroxicam
Indication(s)Piroxicam is used to treat pain and a variety of inflammatory conditions.DAC recommendationThe Drug Advisory Committee (DAC) has recommended that piroxicam be…
Drug formulary listing decision – Pregabalin
Indication(s)Treatment of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, spinal cord injury and pain associated with fibromyalgia.…
Drug formulary listing decision – Skeletal muscle relaxants
Indication(s)The management of discomfort ± acute muscle spasm associated with painful musculoskeletal (MSK) conditions (cylcobenzaprine, methocarbamol, and orphenadrine).The…